FTH1 and clear cell renal carcinoma: In addition, higher expression of OGT, FOXC1, ASNS, GPT2, CBS, or FTH1 was also associated with poorer outcomes in clinical cases with renal clear cell carcinoma or glioma (Fig. S12).